Status:
COMPLETED
Renal Transplantation With Immune Monitoring
Lead Sponsor:
Washington University School of Medicine
Conditions:
Renal Transplantation
Immunosuppression
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this observational study is to evaluate an FDA approved immune system monitoring assay (Immunknow, Cylex Inc. Columbia, MD) in renal transplant recipients using standard immunosuppression a...
Detailed Description
As compared to previous eras, renal transplantation is a procedure associated with low acute rejection rates and excellent one year graft survival. Despite this success, long term graft survival rates...
Eligibility Criteria
Inclusion
- All consenting adult renal transplant recipients (age 18 years of age or older)
- Females of childbearing age must have a negative pregnancy test performed at the time of admission for transplantation
- Patient or guardian agrees to participate in the study and signs the informed consent.
- Patients already consented to another study, if allowed by the study sponsor and PI of that study.
Exclusion
- Pregnant women or nursing mothers
- Any patient who, in the opinion of the investigator, has a significant medical or psychosocial problem that should preclude them from the study.
Key Trial Info
Start Date :
October 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2008
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00419575
Start Date
October 1 2006
End Date
May 1 2008
Last Update
June 5 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University School of Medicine/Barnes-Jewish Hospital
St Louis, Missouri, United States, 63110